Cargando…
Proteinase‐activated receptor 1: A target for repurposing in the treatment of COVID‐19?
In the search to rapidly identify effective therapies that will mitigate the morbidity and mortality of COVID‐19, attention has been directed towards the repurposing of existing drugs. Candidates for repurposing include drugs that target COVID‐19 pathobiology, including agents that alter angiotensin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361899/ https://www.ncbi.nlm.nih.gov/pubmed/32639031 http://dx.doi.org/10.1111/bph.15194 |